ELYRIA, Ohio--(BUSINESS WIRE)--Invacare Corporation (“Invacare”)(NYSE:IVC) released today the following statement from Matt Monaghan, chairman, president and chief executive officer, regarding the impact of the novel COVID-19 on the company.
Business Update
“Invacare is uniquely positioned to be part of the solution combatting this global pandemic as we offer essential healthcare products for those impacted by this virus. Our long-term care beds enable patients to avoid being admitted to hospitals for treatment or to be transitioned out of hospitals and into other care settings, including their homes, to recover. And, our oxygen concentrators provide supplemental oxygen for respiratory care that is a critical part to COVID-19 therapy. These concentrators are effective in any care setting, and are an essential part of delivering care outside increasingly taxed hospital resources. The Invacare team is rising to the challenge of supporting people globally in this critical time.